Literature DB >> 8835554

Analytical and clinical relationships between human IgG autoantibodies to beta 2 glycoprotein I and anticardiolipin antibodies.

H S El-Kadi1, L B Keil, V A DeBari.   

Abstract

OBJECTIVE: To examine IgG anti-beta 2 glycoprotein I (anti-beta 2 GPI) binding in 82 sera referred for anticardiolipin antibody (aCL) testing and to develop preliminary clinical correlations with antiphospholipid syndrome (APS).
METHODS: Immunoassay of IgG cofactor dependent aCL and IgG anti-beta 2 GPI antibodies and retrospective chart review.
RESULTS: Forty-four sera exhibited normal (< or = 22 GPL units) aCL activity, 18 had moderate binding activity (23-45 GPL units), and 20 had high (> or = 46 GPL units) binding activity to cardiolipin. Among these groups, 6 of the 20 sera in the high GPL group had elevated anti-beta 2 GPI. This correlated strongly with 2 or more clinical manifestations of APS.
CONCLUSION: Anti-beta 2 GPI activity may be a more valuable indicator of APS than aCL.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8835554

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  5 in total

1.  Antiphospholipid antibodies affect trophoblast gonadotropin secretion and invasiveness by binding directly and through adhered beta2-glycoprotein I.

Authors:  N Di Simone; P L Meroni; N de Papa; E Raschi; D Caliandro; C S De Carolis; M A Khamashta; T Atsumi; G R Hughes; G Balestrieri; A Tincani; P Casali; A Caruso
Journal:  Arthritis Rheum       Date:  2000-01

2.  Specificity and sensitivity of anti-beta2-glycoprotein I as compared with anticardiolipin antibody and lupus anticoagulant in Thai systemic lupus erythematosus patients with clinical features of antiphospholipid syndrome.

Authors:  Virunya Parkpian; Oravan Verasertniyom; Monchand Vanichapuntu; Kitti Totemchokchyakarn; Kanokrat Nantiruj; Prapaporn Pisitkul; Pantep Angchaisuksiri; Napaporn Archararit; Bupha Rachakom; Katcharin Ayurachai; Suchela Janwityanujit
Journal:  Clin Rheumatol       Date:  2007-03-02       Impact factor: 2.980

3.  Human monoclonal anti-phospholipid antibodies selectively bind to membrane phospholipid and beta2-glycoprotein I (beta2-GPI) on apoptotic cells.

Authors:  V Pittoni; C T Ravirajan; S Donohoe; S J MacHin; P M Lydyard; D A Isenberg
Journal:  Clin Exp Immunol       Date:  2000-03       Impact factor: 4.330

4.  Anti-cardiolipin and anti-beta2-glycoprotein I antibodies in patients with inflammatory bowel disease.

Authors:  I E Koutroubakis; E Petinaki; E Anagnostopoulou; H Kritikos; I A Mouzas; E A Kouroumalis; O N Manousos
Journal:  Dig Dis Sci       Date:  1998-11       Impact factor: 3.199

5.  Standardized measurement of major immunoglobulin class (IgG, IgA, and IgM) antibodies to beta2glycoprotein I in patients with antiphospholipid syndrome.

Authors:  S Lewis; L B Keil; W L Binder; V A DeBari
Journal:  J Clin Lab Anal       Date:  1998       Impact factor: 2.352

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.